2 million prompts in 60 days. Gaia disclosed that figure for its AI Guides beta on March 2 — the first time any spiritual platform has published a hard engagement number for AI-mediated guidance at scale. Gaia is a NASDAQ-listed company with $99M in 2025 revenue, 900,000 members, and eight consecutive quarters of positive free cash flow. That context makes 2 million interactions in two months a market signal, not a product announcement.

The same week, Gloo raised FY2026 revenue guidance to $185M and launched a values-alignment benchmark for LLMs — scoring models across seven human-flourishing dimensions to give faith and wellness organisations an AI procurement filter. On the research side, Nature Neuropsychopharmacology published a comprehensive review of psychedelic therapeutics that consolidates the evidence base into a single citable reference. Alongside it, researchers published evidence that modified psilocin compounds can retain antidepressant mechanism with fewer hallucinogenic effects in preclinical models.

A STAT News investigation into at-home telehealth ketamine platforms is the week's counterweight: when real-time medical supervision is removed, patient safety responsibility shifts to users. That is now a documented finding on the public record, not a regulatory hypothetical.